Mariner
AUGX

Mariner’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Mariner’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-44,944
Closed -$39.6K – 3417
2024
Q2 		$39.6K Hold
44,944
– – ﹤0.01% 3074
2024
Q1 		$184K Buy
44,944
+11,000
+32% +$49.2K ﹤0.01% 2799
2023
Q4 		$199K Buy
33,944
+7,000
+26% +$36.8K ﹤0.01% 2697
2023
Q3 		$139K Hold
26,944
– – ﹤0.01% 2626
2023
Q2 		$130K Hold
26,944
– – ﹤0.01% 2580
2023
Q1 		$47K Hold
26,944
– – ﹤0.01% 2666
2022
Q4 		$42K Buy
26,944
+15,000
+126% +$19.1K ﹤0.01% 2627
2022
Q3 		$17K Buy
+11,944
New +$20.5K ﹤0.01% 2393

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Mariner's AUGX Position: Q3 2024 in Review

Mariner sold out of Augmedix, Inc. Common Stock (AUGX) in Q3 2024, closing a stake of 44,944 shares — an estimated $39.6K sold.

Mariner first reported a position in AUGX in Q3 2022 and held it in 8 quarters. The position peaked at $199K in Q4 2023. 45 funds tracked by Wall St. Rank hold AUGX as of Q3 2024.

  • Mariner reported no remaining Augmedix, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Mariner sold 44,944 Augmedix, Inc. Common Stock shares in Q3 2024, an estimated $39.6K.
  • Mariner first reported a position in Augmedix, Inc. Common Stock in Q3 2022 and held it in 8 quarters.
  • Mariner's Augmedix, Inc. Common Stock position peaked at $199K in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q3 2024.

Based on Mariner's 13F filing for Q3 2024, filed 13 Nov 2024.